| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Nilanjan Ghosh | |
| Vivekananda Mandal | |||
| Subhash C Mandal | |||
| Rituparna Chaki | |||
| P2860 | cites work | Human cyclooxygenase-2 cDNA | Q24293134 |
| Cyclooxygenase regulates angiogenesis induced by colon cancer cells | Q24336248 | ||
| COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression | Q24536398 | ||
| Tumor angiogenesis: therapeutic implications | Q27860595 | ||
| Why there are two cyclooxygenase isozymes | Q27863307 | ||
| The cyclo-oxygenase-2 inhibitor celecoxib perturbs intracellular calcium by inhibiting endoplasmic reticulum Ca2+-ATPases: a plausible link with its anti-tumour effect and cardiovascular risks | Q28193254 | ||
| Induction of cyclooxygenase-2 by activated Ha-ras oncogene in Rat-1 fibroblasts and the role of mitogen-activated protein kinase pathway | Q28279767 | ||
| The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2 | Q28375904 | ||
| Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc(Delta 716) knockout mice | Q28585868 | ||
| Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2) | Q28586461 | ||
| Tumour-educated macrophages promote tumour progression and metastasis | Q29614307 | ||
| Cyclooxygenases: structural, cellular, and molecular biology | Q29616510 | ||
| Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas | Q29620630 | ||
| Carcinogen substrate specificity of human COX-1 and COX-2. | Q31835278 | ||
| Tumor necrosis factor-alpha-induced cyclooxygenase-2 expression via sequential activation of ceramide-dependent mitogen-activated protein kinases, and IkappaB kinase 1/2 in human alveolar epithelial cells. | Q31942027 | ||
| Clinical translation of angiogenesis inhibitors | Q34152769 | ||
| Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis | Q34156486 | ||
| Cyclooxygenase-2: a novel target for cancer chemotherapy? | Q34317347 | ||
| Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer. | Q34571903 | ||
| Calcium-activated endoplasmic reticulum stress as a major component of tumor cell death induced by 2,5-dimethyl-celecoxib, a non-coxib analogue of celecoxib. | Q34618673 | ||
| Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention | Q36002131 | ||
| Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential | Q36085224 | ||
| Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522 | Q36620003 | ||
| Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes | Q36624237 | ||
| Prostaglandin H synthase and xenobiotic oxidation | Q37813447 | ||
| Host cyclooxygenase-2 modulates carcinoma growth. | Q40365112 | ||
| From the cyclooxygenase-2 inhibitor celecoxib to a novel class of 3-phosphoinositide-dependent protein kinase-1 inhibitors | Q40543789 | ||
| 3-phosphoinositide-dependent protein kinase-1/Akt signaling represents a major cyclooxygenase-2-independent target for celecoxib in prostate cancer cells | Q40588085 | ||
| Celecoxib induces apoptosis by inhibiting 3-phosphoinositide-dependent protein kinase-1 activity in the human colon cancer HT-29 cell line | Q40733087 | ||
| Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy | Q40747279 | ||
| Transforming growth factor-beta1 enhances Ha-ras-induced expression of cyclooxygenase-2 in intestinal epithelial cells via stabilization of mRNA. | Q40897760 | ||
| Epidermal growth factor-induced actin remodeling is regulated by 5-lipoxygenase and cyclooxygenase products | Q41534223 | ||
| Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis | Q41709477 | ||
| Inflammatory response: pathway across the blood-brain barrier. | Q43549107 | ||
| Targeting cyclooxygenase 2 and HER-2/neu pathways inhibits colorectal carcinoma growth | Q43619428 | ||
| Prostaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor | Q44375278 | ||
| Celecoxib, a selective cyclo-oxygenase-2 inhibitor, enhances the response to preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer | Q44513206 | ||
| Celecoxib anti-aromatase neoadjuvant (CAAN) trial for locally advanced breast cancer: preliminary report | Q44659442 | ||
| Activators of the nuclear receptor PPARgamma enhance colon polyp formation | Q46754355 | ||
| High expression of cyclooxygenase-2 in macrophages of human colonic adenoma. | Q53418211 | ||
| Chemoprevention of colonic aberrant crypt foci by an inducible nitric oxide synthase-selective inhibitor. | Q53424163 | ||
| Peroxisome proliferators enhance cyclooxygenase-2 expression in epithelial cells. | Q53425584 | ||
| Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2 | Q70787131 | ||
| Cyclooxygenase and lipoxygenase inhibitors as modulators of cancer therapies | Q72314332 | ||
| Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial | Q73224851 | ||
| Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice | Q73693790 | ||
| Dihydroxy bile acids activate the transcription of cyclooxygenase-2 | Q74088917 | ||
| P433 | issue | 2 | |
| P921 | main subject | chemotherapy | Q974135 |
| P304 | page(s) | 233-244 | |
| P577 | publication date | 2010-03-01 | |
| P1433 | published in | Pharmacological Reports | Q15766499 |
| P1476 | title | COX-2 as a target for cancer chemotherapy | |
| P478 | volume | 62 |
| Q33723522 | Abalone visceral extract inhibit tumor growth and metastasis by modulating Cox-2 levels and CD8+ T cell activity. |
| Q42484881 | Aberrant cAMP metabolism in NF1 malignant peripheral nerve sheath tumor cells |
| Q28394475 | Altered prostanoid signaling contributes to increased skin tumorigenesis in Tpl2 knockout mice |
| Q39538500 | Analysis of promoters and expression-targeted gene therapy optimization based on doubling time and transfectability. |
| Q58103540 | Anisotropic Gold Nanoparticles in Biomedical Applications |
| Q36121287 | Antitumor Activity of Cytotoxic Cyclooxygenase-2 Inhibitors |
| Q34612360 | Aqueous extract of the edible Gracilaria tenuistipitata inhibits hepatitis C viral replication via cyclooxygenase-2 suppression and reduces virus-induced inflammation |
| Q42958488 | Aspirin therapy for cancer: it is never too late |
| Q92151229 | Aspirin use and pancreatic cancer risk: A systematic review of observational studies |
| Q38025038 | Aspirin, nonsteroidal anti-inflammatory drugs, paracetamol and risk of endometrial cancer: a case-control study, systematic review and meta-analysis |
| Q89044934 | Autophagy inhibition enhances celecoxib-induced apoptosis in osteosarcoma |
| Q41347995 | Bystander signaling via oxidative metabolism |
| Q27692701 | COX-2 Inhibitors and Gastric Cancer |
| Q42269526 | COX-2, TFF1, and Src define better prognosis in young patients with gastric cancer. |
| Q85304405 | COX-2- and endoplasmic reticulum stress-independent induction of ULBP-1 and enhancement of sensitivity to NK cell-mediated cytotoxicity by celecoxib in colon cancer cells |
| Q89748843 | COX-2/sEH Dual Inhibitor PTUPB Potentiates the Antitumor Efficacy of Cisplatin |
| Q35550041 | Cancer associated fibroblasts in hematological malignancies |
| Q38001305 | Cardiovascular medications in angiogenesis--how to avoid the sting in the tail |
| Q33913432 | Celecoxib decreases growth and angiogenesis and promotes apoptosis in a tumor cell line resistant to chemotherapy |
| Q49304587 | Celecoxib induces cell death on non-small cell lung cancer cells through endoplasmic reticulum stress |
| Q36981423 | Celecoxib inhibits insulin-like growth factor 1 induced growth and invasion in non-small cell lung cancer |
| Q33705269 | Cell-type-specific roles for COX-2 in UVB-induced skin cancer |
| Q83016358 | Chemopreventive effects of NSAIDs on cytokines and transcription factors during the early stages of colorectal cancer |
| Q52606072 | Clinical Significance and Biological Role of HuR in Head and Neck Carcinomas. |
| Q40396217 | Clinical Significance of Hu-Antigen Receptor (HuR) and Cyclooxygenase-2 (COX-2) Expression in Human Malignant and Benign Thyroid Lesions |
| Q83506567 | Combination of EGFR and COX-2 inhibitors in breast cancer patient |
| Q41270773 | Combination of celecoxib (Celebrex®) and CD19 CAR-redirected CTL immunotherapy for the treatment of B-cell non-Hodgkin's lymphomas |
| Q34060461 | Conjugates of cisplatin and cyclooxygenase inhibitors as potent antitumor agents overcoming cisplatin resistance. |
| Q35334366 | Conjugation of cisplatin analogues and cyclooxygenase inhibitors to overcome cisplatin resistance. |
| Q36594073 | Cox-2 inhibition enhances the activity of sunitinib in human renal cell carcinoma xenografts. |
| Q35081466 | Cyclooxygenase-2 and B-cell lymphoma-2 expression in cystitis glandularis and primary vesicle adenocarcinoma |
| Q55308883 | Cyclooxygenase-2 immunoexpression in intestinal epithelium and lamina propria of cats with inflammatory bowel disease and low grade alimentary lymphoma. |
| Q38969912 | Cyclooxygenase-2 in glioblastoma multiforme |
| Q36557393 | Cyclooxygenase-2 in tumor-associated macrophages promotes breast cancer cell survival by triggering a positive-feedback loop between macrophages and cancer cells |
| Q37513938 | Cyclooxygenase-2 in tumor-associated macrophages promotes metastatic potential of breast cancer cells through Akt pathway |
| Q58546808 | Cyclooxygenase-2 inhibition potentiates the efficacy of vascular endothelial growth factor blockade and promotes an immune stimulatory microenvironment in preclinical models of pancreatic cancer |
| Q37407198 | Cyclooxygenase-2 is associated with malignant phenotypes in human lung cancer |
| Q34224752 | Cyclooxygenases and lipoxygenases in cancer |
| Q38951209 | Cytotoxicity of selected novel chalcone derivatives on human breast, lung and hepatic carcinoma cell lines |
| Q90193038 | Dietary Polyacetylenic Oxylipins Falcarinol and Falcarindiol Prevent Inflammation and Colorectal Neoplastic Transformation: A Mechanistic and Dose-Response Study in A Rat Model |
| Q38534570 | Direct molecular targets of resveratrol: identifying key interactions to unlock complex mechanisms. |
| Q28575323 | Down-regulated CFTR During Aging Contributes to Benign Prostatic Hyperplasia |
| Q42376638 | Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas |
| Q33588277 | Downregulation of mitochondrial cyclooxygenase-2 inhibits the stemness of nasopharyngeal carcinoma by decreasing the activity of dynamin-related protein 1. |
| Q39204898 | Ectopic expression of miR-34a enhances radiosensitivity of non-small cell lung cancer cells, partly by suppressing the LyGDI signaling pathway |
| Q57127956 | Effects of postoperative non-steroidal anti-inflammatory drugs on long-term survival and recurrence of patients with non-small cell lung cancer |
| Q33771427 | Effects of resveratrol on drug- and carcinogen-metabolizing enzymes, implications for cancer prevention |
| Q33670223 | Elevated COX-2 Expression Promotes Angiogenesis Through EGFR/p38-MAPK/Sp1-Dependent Signalling in Pancreatic Cancer |
| Q38624619 | Elevated Hu-Antigen Receptor (HuR) Expression is Associated with Tumor Aggressiveness and Poor Prognosis but not with COX-2 Expression in Invasive Breast Carcinoma Patients |
| Q53181748 | Endogenous conversion of ω-6 to ω-3 polyunsaturated fatty acids in fat-1 mice attenuated intestinal polyposis by either inhibiting COX-2/β-catenin signaling or activating 15-PGDH/IL-18. |
| Q53119009 | Enhanced Anti-Inflammatory Activities by the Combination of Luteolin and Tangeretin. |
| Q35176423 | Epidermal growth factor-induced cyclooxygenase-2 enhances head and neck squamous cell carcinoma metastasis through fibronectin up-regulation |
| Q47976968 | Expression of prostaglandin E2 and EP receptors in human papillary thyroid carcinoma |
| Q39114231 | Glucose-regulated protein 78 mediates hormone-independent prostate cancer progression and metastasis through maspin and COX-2 expression |
| Q44445934 | Hu-antigen receptor (HuR) and cyclooxygenase-2 (COX-2) expression in human non-small-cell lung carcinoma: associations with clinicopathological parameters, tumor proliferative capacity and patients' survival. |
| Q37252826 | Human cytomegalovirus IE1 protein disrupts interleukin-6 signaling by sequestering STAT3 in the nucleus. |
| Q37221954 | In Vitro Cytotoxic Effects of Celecoxib, Mefenamic Acid, Aspirin and Indometacin on Several Cells Lines |
| Q54719345 | Inhibitory effect of phytoglycoprotein (24 kDa) on hepatocarcinogenesis in N-nitrosodiethylamine-treated ICR mice. |
| Q30439733 | Inhibitory effects of subcutaneous tumors in nude mice mediated by low-frequency ultrasound and microbubbles |
| Q42643167 | Isolation and characterization of three new anti-proliferative Sesquiterpenes from Polygonum barbatum and their mechanism via apoptotic pathway. |
| Q64917104 | Knockdown of cyclooxygenase-2 leads to growth inhibition and cell cycle arrest in hepatocellular carcinoma cells. |
| Q85908360 | Large (>3.8 cm) clear cell renal cell carcinomas are morphologically and immunohistochemically heterogeneous |
| Q39544493 | Lunasin-aspirin combination against NIH/3T3 cells transformation induced by chemical carcinogens. |
| Q42160346 | Lymphangiogenesis in non-Hodgkin's lymphoma and its correlation with cyclooxygenase-2 and vascular endothelial growth factor-C. |
| Q35653603 | Marketed nonsteroidal anti-inflammatory agents, antihypertensives, and human immunodeficiency virus protease inhibitors: as-yet-unused weapons of the oncologists' arsenal |
| Q64955692 | Mechanism of Apoptosis Induced by Curcumin in Colorectal Cancer. |
| Q45922732 | Melatonin overcomes apoptosis resistance in human hepatocellular carcinoma by targeting survivin and XIAP. |
| Q38724921 | Nanoparticle-Based Celecoxib and Plumbagin for the Synergistic Treatment of Melanoma. |
| Q38047351 | Non-steroidal anti-inflammatory treatment in cancer cachexia: a systematic literature review |
| Q34168476 | Nuclear receptors and pathogenesis of pancreatic cancer. |
| Q39392716 | OSU-03012 suppresses GRP78/BiP expression that causes PERK-dependent increases in tumor cell killing |
| Q92865237 | Opioids in Cancer Development, Progression and Metastasis: Focus on Colorectal Cancer |
| Q47450453 | Oral administration of lyophilized Dunaliella salina, a carotenoid-rich marine alga, reduces tumor progression in mammary cancer induced rats |
| Q36129926 | Ortho-carbaborane derivatives of indomethacin as cyclooxygenase (COX)-2 selective inhibitors |
| Q36834358 | PET imaging of cyclooxygenase-2 (COX-2) in a pre-clinical colorectal cancer model |
| Q42560760 | PPARγ and Oxidative Stress: Con(β) Catenating NRF2 and FOXO |
| Q47742647 | Pilot study: duodenal MDR1 and COX2 gene expression in cats with inflammatory bowel disease and low-grade alimentary lymphoma |
| Q60328228 | Platinum(IV) Prodrugs - A Step Closer to Ehrlich's Vision? |
| Q33783981 | Prokaryotic expression, purification and characterization of human cyclooxygenase-2. |
| Q92238020 | Prostaglandin E2 Signals Through E Prostanoid Receptor 2 to Inhibit Mitochondrial Superoxide Formation and the Ensuing Downstream Cytotoxic and Genotoxic Effects Induced by Arsenite |
| Q35219865 | Prostaglandin E2 and the pathogenesis of pulmonary fibrosis. |
| Q92154739 | Raddeanin A promotes apoptosis and ameliorates 5-fluorouracil resistance in cholangiocarcinoma cells |
| Q38113933 | Radiolabeled COX-2 inhibitors for non-invasive visualization of COX-2 expression and activity--a critical update |
| Q37852512 | Recent advances in anti-angiogenic therapy of cancer |
| Q42711485 | Reciprocal regulation of cyclooxygenase 2 and heme oxygenase 1 upon arsenic trioxide exposure in normal human lung fibroblast |
| Q26771416 | Red Meat and Colorectal Cancer |
| Q39843650 | Regulation of Apoptosis by HER2 in Breast Cancer |
| Q38174447 | Research progress of ursolic acid's anti-tumor actions |
| Q33646333 | Restoration of E-cadherin expression by selective Cox-2 inhibition and the clinical relevance of the epithelial-to-mesenchymal transition in head and neck squamous cell carcinoma |
| Q40289814 | Role of Cyclooxygenase-2 on Intermittent Hypoxia-Induced Lung Tumor Malignancy in a Mouse Model of Sleep Apnea. |
| Q35465562 | Role of cyclooxygenase-2 gene polymorphisms in pancreatic carcinogenesis |
| Q91742634 | Selective EP2 and Cox-2 inhibition suppresses cell migration by reversing epithelial-to-mesenchymal transition and Cox-2 overexpression and E-cadherin downregulation are implicated in neck metastasis of hypopharyngeal cancer |
| Q36536476 | Simultaneous targeting of COX-2 and AKT using selenocoxib-1-GSH to inhibit melanoma |
| Q53280848 | Status and significance of CpG island methylator phenotype in endometrial cancer. |
| Q39218093 | Sulindac sulfide inhibits sarcoendoplasmic reticulum Ca2+ ATPase, induces endoplasmic reticulum stress response, and exerts toxicity in glioma cells: relevant similarities to and important differences from celecoxib |
| Q37039298 | Synergistic antitumor activity of reversine combined with aspirin in cervical carcinoma in vitro and in vivo |
| Q53554210 | Synergistic effect between celecoxib and luteolin is dependent on estrogen receptor in human breast cancer cells. |
| Q36105949 | Synthesis and evaluation of carbaborane derivatives of indomethacin as cyclooxygenase inhibitors. |
| Q54717485 | Synthesis of three 18F-labelled cyclooxygenase-2 (COX-2) inhibitors based on a pyrimidine scaffold. |
| Q89512930 | Synthesis, anti-inflammatory, cytotoxic, and COX-1/2 inhibitory activities of cyclic imides bearing 3-benzenesulfonamide, oxime, and β-phenylalanine scaffolds: a molecular docking study |
| Q90401790 | Synthesis, antitumor activity, and molecular docking study of 2-cyclopentyloxyanisole derivatives: mechanistic study of enzyme inhibition |
| Q54338265 | TGF β1 mediates epithelial mesenchymal transition via β6 integrin signaling pathway in breast cancer. |
| Q45363189 | Targeted Delivery of siRNA with pH-Responsive Hybrid Gold Nanostars for Cancer Treatment. |
| Q39027675 | Targeting Inflammation in Cancer Prevention and Therapy |
| Q84474553 | Targeting myeloid regulatory cells in cancer by chemotherapeutic agents |
| Q91928988 | Targeting the Canonical WNT/β-Catenin Pathway in Cancer Treatment Using Non-Steroidal Anti-Inflammatory Drugs |
| Q40084585 | Technetium-99m based small molecule radiopharmaceuticals and radiotracers targeting inflammation and infection. |
| Q36303103 | The HMGA1-COX-2 axis: a key molecular pathway and potential target in pancreatic adenocarcinoma |
| Q35206661 | The colorectal tumor microenvironment: the next decade |
| Q37457596 | The effect of celecoxib on tumor growth in ovarian cancer cells and a genetically engineered mouse model of serous ovarian cancer |
| Q57826180 | Tomato powder impedes the development of azoxymethane-induced colorectal cancer in rats through suppression of COX-2 expression via NF-κB and regulating Nrf2/HO-1 pathway |
| Q54108527 | Triple action Pt(iv) derivatives of cisplatin: a new class of potent anticancer agents that overcome resistance. |
| Q53155954 | Upregulation of intrinsic apoptotic pathway in NSAIDs mediated chemoprevention of experimental lung carcinogenesis. |
Search more.